United States · Series A startup

Who invested in Stelexis Therapeutics

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 27 Oct 2026

$43Mraised across 1 round since 2019, from 1 source

Latest round
Series A, $43MJan 2019
Investors
2
See who backed them

The rounds

  1. Jan 2019
    Series A$43M

    Reported by FinSMEs

Everyone who backed them

LD CapitalVC firm1round
DeerfieldVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Stelexis Therapeutics

Who invested in Stelexis Therapeutics?

Stelexis Therapeutics's investors include LD Capital and Deerfield.

How much has Stelexis Therapeutics raised?

Stelexis Therapeutics has raised $43M across 1 round since 2019.

When did Stelexis Therapeutics last raise?

Stelexis Therapeutics's most recent round was a Series A of $43M in Jan 2019.

What was Stelexis Therapeutics's biggest round?

Its most recent round, $43M in Jan 2019, is also its largest on record.

Who backed Stelexis Therapeutics first?

Stelexis Therapeutics's first round on record, in Jan 2019, was backed by LD Capital and Deerfield.

What stage is Stelexis Therapeutics at?

Stelexis Therapeutics's latest named round is a Series A, in Jan 2019.

Where is Stelexis Therapeutics based?

Stelexis Therapeutics is based in the United States.

Companies like Stelexis Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.